Promisia Healthcare Limited logo

Notice of Special Meeting

AGM15 March 2022PHLHealthcare

14521281_1

15 March 2022






Dear Shareholder


Please find enclosed notice of Promisia Healthcare Limited’s (PHL) special meeting of shareholders

which will be held virtually via Link Market Services’ virtual meeting platform at

www.virtualmeeting.co.nz/phlsm22 on Wednesday, 30 March 2022 starting at 11am.


Capitalised terms used in this letter will, unless otherwise defined, have the meaning given to them in

the Glossary, contained in the enclosed Notice of Meeting.


Background


On 23 December 2021, PHL’s wholly owned subsidiary Aldwins House Limited entered into a conditional

Agreement for Sale and Purchase of Real Estate with the Vendor to acquire the freehold title to the

Aldwins Facility. AHL currently leases the Aldwins Facility from the Vendor and provides rest home,

respite, hospital level and palliative care to the elderly with the capacity to care for up to 145 residents.


AHL currently operates the Aldwins Facility at a financial loss. PHL has been funding these losses from

the profits it generates at its other three facilities. The key driver of revenue at the Aldwins Facility is its

occupancy level, which has built gradually to approximately 50 residents since opening.


As was recently announced to the market, an opportunity to have up to 40 new residents transferred to

the Aldwins Facility from another Christchurch facility has arisen. AHL is in the process of speaking with

those potential residents and seeking their agreement to transfer to the Aldwins Facility. If a large

proportion do agree to transfer to the Aldwins Facility, the Aldwins Facility could become profitable for

the 2023 financial year. PHL will update the market on the outcome of these discussions in around one

week’s time.


A significant expense for the Aldwins Facility is rent. Rent exceeds the interest cost that AHL would incur

through acquiring the Aldwins Facility using debt funding under this transaction, improving its

profitability. In addition, the Board considers that there is a good prospect of the Aldwins Facility

appreciating in capital value over time. For these reasons the Board has decided to proceed with the

Acquisition subject to shareholder approval.


Aldwins Facility Acquisition


The Purchase Price of the Aldwins Facility is $13,000,000 plus GST (if any). The Aldwins Facility is

situated on a freehold title of approximately 8,244m

2

in central Christchurch.


The Board proposes to finance the Acquisition from the following sources:


• AHL drawing a term loan from the Vendor of $4 million at Completion;


• AHL drawing a new $7.5 million debt facility from Bank of New Zealand; and


• PHL drawing on a $1.5 million extension of its current debt facility with Senior Trust Retirement

Village Income Generator Limited.


The Acquisition is conditional on PHL shareholder approval under Listing Rule 5.1.1(b). Subject to this

condition being satisfied or waived, the Acquisition will settle on 31 March 2022 or five working days

from the date all conditions are waived or satisfied (whichever date is earlier).


14521281_1 2

Benefits of the Acquisition


The Board considers the Acquisition to be in the best interests of PHL, as it will:


• enlarge PHL’s property portfolio and bring the Aldwins Facility in line with PHL’s strategy of

owning rather than leasing its aged care facilities;


• reduce PHL’s short term cash burn associated with the Aldwins Facility (by bringing the Lease

to an end) and improve the profitability of the Aldwins Facility; and


• support PHL making further investment in the Aldwins Facility, particularly in sales and

marketing initiatives to increase occupancy.


If the Acquisition does not proceed, PHL may incur losses in AHL for a longer period. The Board will

need to consider whether PHL allocating capital to fund those losses is the best use of that capital or

whether AHL’s current operations at the Aldwins Facility should be sold or wound down.


Approvals Sought


Under the Listing Rules, approval of PHL’s shareholders is required to proceed with the Acquisition. A

description of the Acquisition and the requirement for the Resolution to be considered at the Meeting

are set out in the enclosed Notice of Meeting.


The Resolution being put forward at the Meeting will, if passed, authorise the Board to proceed under

the Listing Rules with the Acquisition.


Board Recommendation


The Board considers that the Acquisition is in the best interests of PHL and its shareholders and

recommends that shareholders vote in favour of the Resolution outlined in the enclosed Notice of

Meeting. The Board encourages you to read the Notice of Meeting and to exercise your right to vote.


The enclosed Proxy Form has detailed instructions on how shareholders may lodge their vote or appoint

a proxy to vote on their behalf if they are unable to attend the meeting online. Shareholders may submit

specific questions to the Board at any time in advance of the meeting by emailing me at

stephen@renouf.co.nz.


I look forward to seeing you at the meeting.





Stephen Underwood

Chairman


14521281_1 3

NOTICE OF SPECIAL MEETING


If you have sold or otherwise transferred all of your shares in PHL, please pass this Notice of

Meeting, together with all accompanying documents, as soon as possible to the purchaser or

transferee or to the broker or other person who arranged the sale or transfer of your shares.


Notice is hereby given that a special meeting (Meeting) of shareholders of Promisia Healthcare Limited

(PHL) will be held virtually via Link Market Services’ virtual meeting platform at

www.virtualmeeting.co.nz/phlsm22 on Wednesday, 30 March 2022 starting at 11am.


Capitalised terms used in this Notice of Meeting have the meaning given to them in the Glossary to this

Notice of Meeting.

AGENDA

A. Chair’s introduction.

B. Presentation to shareholders.

C. Shareholder discussion.

D. Resolution.

RESOLUTION


To consider and, if thought fit, to pass the following ordinary resolution:


Approval of Acquisition: That, under Listing Rule 5.1.1(b), PHL undertaking the Acquisition

and entering all associated financing for the Acquisition on the basis described in this Notice of

Meeting is approved.


PROCEDURAL NOTES

Proxies

Any shareholder of PHL who is entitled to attend and vote at the Meeting may appoint a proxy to attend

and vote on their behalf. A corporation which is a shareholder may appoint a representative to attend

the Meeting on its behalf in the same manner as it could appoint a proxy. A proxy does not need to be

a shareholder of PHL. A Proxy Form can be returned by delivery, mail, email or online (as set out

below).

The Chair of the Meeting (Mr. Stephen Underwood) and any of the Directors are prepared to act as

proxy. Where any Director is appointed as a discretionary proxy, each of the Directors intends to vote

in favour of the Resolution.

To appoint a proxy you should complete and sign the enclosed Proxy Form and either return it by

delivery, mail or email to the share registrar of PHL:

By delivery:

Promisia Healthcare Limited

C/- Link Market Services Limited

Level 30, PwC Tower

15 Customs Street West

Auckland 1010

By mail:

Promisia Healthcare Limited

C/- Link Market Services Limited

PO Box 91976

Auckland 1142

By email: meetings@linkmarketservices.co.nz (please put the words “Promisia Healthcare

Limited Proxy Form” in the subject line for easy identification)


You may also lodge your proxy online at https://investorcentre.linkmarketservices.co.nz/voting/PHL.

You will require your CSN/Holder Number and FIN to complete your proxy appointment. A shareholder

will be taken to have signed the Proxy Form by lodging it in accordance with the instructions on the

website.


14521281_1 4

The completed Proxy Form must be received by Link Market Services no later than 48 hours before the

Meeting, being 11am on Monday, 28 March 2022. Online proxy appointments must also be completed

by this time. Registered shareholders at that time will be the only persons entitled to vote at the Meeting

and only the shares registered in those shareholders’ names at that time may be voted at the Meeting.

Ordinary Resolution

The Resolution is an ordinary resolution. An ordinary resolution is a resolution passed by a simple

majority of votes of those shareholders entitled to vote and voting on the resolution in person or by

proxy.

Voting Restrictions


There are no voting restrictions applicable to the Resolution.


NZX No Objection


This Notice of Meeting has been reviewed by NZ RegCo. NZ RegCo has confirmed that it has no

objection to this Notice of Meeting.


14521281_1 5

EXPLANATORY NOTES


ABOUT THE ALDWINS FACILITY


The Aldwins Facility opened to residents in December 2020 after undergoing earthquake strengthening

work and completing a thorough refurbishment. The Aldwins Facility is located in central Christchurch

and comprises of approximately 4,288 m2 of buildings on 8,241 m2 of land. The complex consists of

145 bedrooms, most with ensuite bathrooms. AHL currently employs 40 staff at the Aldwins Facility.


The amenities at the Aldwins Facility include a reception foyer, open plan entertainment hall with

adjoining kitchenette and hair salon/beauty room, dining room serviced by a large commercial grade

kitchen, nurses’ stations, sitting rooms, staffroom, administration offices, sheltered communal outdoor

areas situated within two internal courtyards, 75 car parking spaces and two double-width bed sized

elevators.


The Aldwins Facility has Ministry of Health certification for providing rest home, respite, hospital level

and palliative care to the elderly. This certification enables the Aldwins Facility to receive Government

funded residents and patient referrals from the Canterbury District Health Board. The Aldwins Facility is

currently certified to 27 November 2024 and is subject to regular audits to assess the services provided

to residents and the physical environment of the Aldwins Facility. In its October 2021 audit, the Aldwins

Facility achieved full attainment of all standards it was audited against

1

.


In addition to those referrals, the Aldwins Facility also obtains residents through families looking for care

for their elderly relatives. Revenue is derived from the Canterbury District Health Board (on a per person

per night basis) and from residents for additional services that they or their families fund directly.


The Aldwins Facility is owned by the Vendor with AHL as the tenant under the Lease. AHL commenced

renting the Aldwins Facility on 1 March 2020. Annual rent for the Aldwins Facility is $1,060,000 plus

GST.


DECISION TO ACQUIRE THE ALDWINS FACILITY


PHL acquired AHL in October 2020 as part of a wider transaction where it acquired three aged care

facilities in the North Island. As part of the acquisition PHL also acquired an option to purchase the

Aldwins Facility for $11,000,000. The Board decided to not exercise the option and it lapsed on 9 August

2021. At the time the option lapsed the Board was aware that further works and investment on the

Aldwins Facility were needed and occupancy growth at the Aldwins Facility was slower than anticipated.

For these reasons AHL was not positioned to seek debt finance and fund the exercise of the option at

that time.


Over subsequent months occupancy rates improved and showed a more consistent trend at the Aldwins

Facility. AHL has also developed a clearer understanding of the repairs and maintenance work needed

in the Aldwins Facility. Under AHL’s ownership some roof repairs to the Aldwins Facility will be needed

together with various other minor works. The Board estimates that expenditure of $300,000 will be

required in the next 12 months to remedy all outstanding repair and maintenance issues and these

expenses can be funded out of Group cashflows as they arise, without further debt or a capital raising

by PHL being required.


In addition to these investigations and as a more consistent occupancy improvement rate at AHL

developed (see graph below), AHL commissioned a valuation report on the Aldwins Facility from CBRE

Limited to assist its decision making in whether to acquire the Aldwins Facility. The valuation was

prepared as at 9 September 2021 and valued the Aldwins Facility at $14,150,000. The valuation was

prepared as a market valuation on a freehold going concern basis inclusive of land, buildings, chattels

and business disregarding the Lease. The Board does not consider that the value of the Aldwins Facility

will have changed materially since the date of this valuation. A new valuation has not been

commissioned and made available to shareholders. The Board considers that the cash costs and time

costs incurred in arranging such a valuation report outweigh the benefits that any such valuation report


1

A copy of the audit report can be viewed at

https://www.health.govt.nz/sites/default/files/prms/audit_summaries/AuditSummary_PRMS_CommunicatePublish_0000196440

01.docx


14521281_1 6

would provide to shareholders given that acquiring aged care and retirement village assets is part of the

Group’s core business.


With this additional information the Board decided to negotiate with the Vendor with a view to acquiring

the Aldwins Facility and, to part fund the transaction, negotiated the Vendor Finance aspect of the

transaction. The outcome of these negotiations was a purchase price of $13 million and the Vendor

Finance terms as set out further below.


The Board approved these key terms and entered a sale and purchase agreement on 23 December

2021. The agreement was subject to a finance condition. This enabled the Board to ascertain total

interest costs in acquiring the Aldwins Facility and assess them against rent costs that would otherwise

be incurred. The finance condition was satisfied on 4 March 2022 following receipt of finance offers for

the BNZ Finance and the Senior Trust Finance which are detailed further below. In addition, the Board

considered the operating losses being incurred at the Aldwins Facility and projections for increases in

revenue at the Aldwins Facility (using an assumption of increasing occupancy at a rate of between 3-4

additional residents per month). This assessment was done for reassurance that the Group had the

financial capacity to fund AHL through to profitability. The Board was satisfied following these

assessments that acquiring the Aldwins Facility on the negotiated terms with the Vendor was in the best

interests of the Group and that there was a reasonable prospect of AHL becoming a contributor of profit

to the Group.


In completing due diligence enquiries and negotiating the Acquisition, the Board has relied on its

executive team (given its depth of sector and financial experience) together with external legal advice.

Other external consultants, such as building and engineering consultants were not engaged to assist in

the Acquisition given major strengthening and refurbishment works were undertaken on the Aldwins

Facility only two years ago and, since then, AHL has developed an extensive understanding of the

Aldwins Facility through its tenancy under the Lease.


OPERATING PERFORMANCE AT THE ALDWINS FACILITY


The Aldwins Facility is currently operating at a loss. The key driver of revenue for the Aldwins Facility is

occupancy rates. At the present time, 60 rooms (the downstairs of the Aldwins Facility) have been

opened. As at 4 March 2022, 52 of the 145 rooms are occupied by residents. The average monthly

occupancy is currently 34%.




AHL has an operating loss of $1.169m for the period 1 April 2021 to 31 January 2022. The monthly loss

is reducing as occupancy increases, resulting in increasing revenues, improving operational efficiencies

and fixed overheads being spread across higher gross earnings.


14521281_1 7

The Board estimates that breakeven for AHL will be achieved at an occupancy level of 80 residents

(55% occupancy) where the Aldwins Facility is leased. It is estimated that this will reduce to 70 residents

(48% occupancy) if the facility is owned. Cash breakeven is expected to reduce from 70 residents (55%)

to 60 residents (41%) if the facility is owned.


As announced recently, another aged care facility in Christchurch is closing and AHL has offered to take

on its 40 residents. Each resident must agree to transfer to the Aldwins Facility and an update on

occupancy will be given at the meeting.


The following information sets out the cash and non-cash monthly costs of leasing the Aldwins Facility

against the anticipated monthly costs of owning the Aldwins Facility:



Impact of moving from Lease to ownership of Aldwins Facility

Lease Scenario$

Monthly Lease payment 88,333

IFRS16 profit & loss lease reporting

Monthly depreciation of right to use asset55,596

Monthly interest cost on Lease47,688

Monthly Lease related costs charged to P&L103,284

Notes:

Ownership Scenario

Expected monthly loan interest costs are as follows

BNZ Finance7,500,000

Interest Rate5.22%

Senior Trust Finance1,500,000

Interest rate10.75%

Vendor Finance4,000,000

Interest rate6%

Estimated monthly interest costs66,100$

Incremental depreciation on building

Purchase price13,000,000

Government valuation of land1,430,000

Estimated value of building & PPE11,570,000

Estimated monthly depreciation over 50 years19,283

Total estimated interest cost plus depreciation85,383$

Estimated reduction in reported expenses17,901$

1. Other costs such as insurance, rates and routine repairs and maintenance are

already covered by AHL under the lease and will also be incurred from an ownership

perspective

2. Under ownership scenario the IFRS16 lease costs shown above are replaced by

interest expense.


14521281_1 8

Under IFRS rules the current lease is capitalised as a right of use asset (ROU) with a corresponding

lease liability. The ROU asset is then depreciated and interest, associated with the lease liability, is

charged on a monthly basis. These two items generate a charge to the AHL profit and loss of $103,000

per month. This compares to the monthly lease cash cost of $88,333 (plus GST) per month. The

following information sets out the anticipated balance sheet adjustments that will arise following the

Acquisition:




If AHL purchases the facility, operating costs will reduce by approximately $10,000 per month (difference

between IFRS accounting for the lease when compared to the loan interest costs plus building

depreciation). From a cash perspective operating cash flow will improve by approximately $20,000 per

month (difference between lease cost and interest on loans). These amounts may vary with changes in

interest rates on the BNZ Finance. In addition, two years following Completion, AHL will commence

making principal repayments on the Vendor Finance. AHL will need to continue to increase revenue

through occupancy growth at the Aldwins Facility to meet such medium to longer term payment

obligations or rely on financial support from the Group.


Following Completion, AHL will focus on increased sales and marketing activity at AHL to lift occupancy

rates to break even. The Board considers that the demographics driving the need for aged care facilities

will support its efforts to increase occupancy. AHL will also investigate development opportunities at the

Aldwins Facility to see if further investment (in the medium term) may increase its revenue earning

potential and capital value.


THE DEBT FACILITIES


The Purchase Price for the Acquisition is $13,000,000 plus GST (if any). The Purchase Price is to be

funded from three sources of debt:


• Vendor Finance: finance to be provided by the Vendor to AHL from Completion of $4 million;


Impact of Aldwins Facility Acquisition

Current Balance Sheet related to Aldwins House Property

As at 31 Jan 2022

Right to Use Asset

10,007,396



Right to Use Asset - Accumulated depreciation

722,756

-


9,284,640



Lease Liabilty

10,039,854

-


Net Liability

755,214

-


After acquisition

Aldwins House Land & Buildings (at purchase cost)

13,000,000



Debt on acquisition (at a Group level)

13,000,000

-


Net position

-



Net increase in assets

3,715,360



Net Increase in liabilities

2,960,146



Net improvement in reported net asset position relating to transaction

755,214



Note: on acquisition the lease liability will be washed out of the balance sheet

and replaced with the acquired asset and loans


14521281_1 9

• BNZ Finance: AHL drawing down a new debt facility from Bank of New Zealand of $7.5 million

at Completion; and


• Senior Trust Finance: Ranfurly Manor (the owner of the group’s Feilding based aged care

facility) increasing its existing debt facility with Senior Trust Retirement Village Income

Generator Limited by $1.5 million (from $5 million to $6.5 million) and making an intra group

advance to AHL.


Following Completion and based on the last completed valuations of the properties (which are between

six and twelve months old) the Group will own properties of an aggregate value of $46.9m and will have

total debt finance of $30.1 million representing 64.3% of the aggregate valuations.


Particulars of each Debt Facility and related security arrangements are as follows:


Vendor Finance


Term Five years following Completion

Principal sum of the loan $4,000,000

Ordinary interest rate 6% per annum (fixed for term)

Penalty interest rate 10% per annum

Interest payments Monthly, in arrears

Repayment – first two years of

the term

Interest only to be paid by AHL.

Repayment – final three years of

the term

Interest and principal payable by AHL, with principal repayments

to be no less than $20,000 per month

Security To secure the Vendor Loan, the following will be granted to the

Vendor:

• a second ranking mortgage over the Aldwins Facility; and

• a second ranking general security interest over all present

and after acquired property of Aldwins House Limited

(7832936) (a subsidiary of PHL).


BNZ Finance


Term Three years.

Principal sum of the loan $7,500,000

Ordinary interest rate Indicative rate of 5.22% per annum. This rate is variable and the

Board may look at fixing the rate in respect of all or part of the

loan following Completion depending upon the prevailing

interest rate environment. Fixed rates presently available are

1% - 1.7% higher than this indicative rate depending on the term

for term for fixing.

Interest payments Monthly, in arrears

Repayment Interest only to be paid by AHL.


14521281_1 10

Financial Covenants The Group must maintain a loan to value ratio of no more than

50%. Subordinated debt (such as the Vendor Finance) is

excluded from this LVR calculation. Based on the last

commissioned valuations for the Aldwins Facility and the

properties that the Group owns, following Completion the LVR

under this covenant will be 41.9%

The EBITDA of the Group must be maintained at a minimum of

2.0 times gross interest expense. Management modelling of this

covenant indicates the Group should satisfy this covenant with

a ratio of just under 3 times. The core assumption underlying

such modelling is maintaining occupancy rates at the Group’s

existing facilities and growing occupancy at the Aldwins Facility

as detailed above.

Security The following is to be provided to secure the Lender Facility:

• first ranking mortgage over the Aldwins Facility.

• first ranking general security over all present and after

acquired property of AHL.

• interlocking guarantee from AHL and each company in the

Group where each Group company guarantees the

obligations of the other to BNZ. This interlocking guarantee

is supported by general security agreements over each

member of the Group (which, other than in the case of

AHL, are already in place).


Senior Trust Finance


Term Four years from 30 October 2020

Principal sum of the loan $1,500,000 (as an increase to the existing $5 million facility of

which Ranfurly Manor is the Borrower)

Ordinary interest rate 10.75% per annum, fixed for the term of the loan.

Penalty interest rate 15.75% per annum

Interest payable from Completion

Interest payments Monthly in arrears

Repayment

Interest only payments are required during the Term with the

facility repayable in full at the end of the Term.

Ranfurly Manor may repay up to $1.25 million of the facility

annually from 30 October 2022 onwards.

Financial Covenants LVR ratio for Ranfurly Manor facility and the Nelson Street

facility is not to exceed 75% during the term of the facility. Based

on the last commissioned valuations for these properties, the

LVR under this covenant is 59.7%.

Security The following continues as security for the Senior Trust Finance:

• Second ranking mortgage over the land and building

owned by Ranfurly Manor.


14521281_1 11

• Guarantee of Ranfurly Manor’s obligations by PHL, Aged

Care Holdings Limited, Nelson Street Resthome Limited

and Ranfurly Manor Limited.


The following sets out the current debt facilities and key debt terms of the Group together with

summary information on the new Debt Facilities:




The Board has decided to finance the Acquisition through the Debt Facilities rather than raise new

capital as it considers that at the present time any capital raising would likely require such a raise to be

undertaken at a discount to PHL’s market price to be successful. The Board would prefer to raise capital

on terms advantageous to shareholders and believes that is more likely to occur where the capital is

being raised to support an entirely new acquisition and expansion of the Group’s operations.


The Vendor Finance was secured as an alternative to the Group raising capital to fund the Acquisition.

As the Vendor Finance has a fixed rate of interest at 6% per annum and a five year term, the Board

considered that this gave expense certainty and time for the Aldwins Facility to become a contributor of

profit to the Group. BNZ, as the Group’s principal financier offered to provide up to $7.5 million of first

mortgage finance on the Aldwins Facility. Senior Trust, as the Group’s current mezzanine finance

provider agreed to finance the $1.5 million difference. The Board considered that this mix of lending and

its average interest cost (compared to rental under the Lease) justified proceeding with the Acquisition.


As shown in the table above, no debt facilities of the Group mature for another 30 months. Over this

time debt will be paid down through profits earned from the Group’s operations. In addition, the Board

will pursue its growth strategy and continue to investigate new acquisitions in the aged care sector which

would likely involve the Group raising new capital and taking on more debt. As its debt facilities mature,

the Group will look to refinance based on the prevailing circumstances of the Group and the prevailing

availability of credit.


OTHER PROVISIONS TO THE ACQUISITION


If the Acquisition is approved by shareholders, Completion will occur on or before 31 March 2022 unless

an extension is agreed with the Vendor. Shareholder approval is the sole outstanding condition.


The Acquisition is documented in a customary form of agreement for sale and purchase of real estate

and, in light of AHL currently tenanting the Aldwins Facility, provides that AHL is acquiring the Aldwins

Group Debt Structure

Existing Drawndown Facilities

Current

Loan Value

($)

Interest

Rate

Term

(Months)RepayableComments

Senior Trust

Ranfurly Manor5,000,00010.75%48Sep-24Interest only

BNZ

Eileen Mary2,900,000Floating36Oct-23Interest only

Ranfurly Manor5,430,000Floating36Oct-23Interest only

Ranfurly Manor2,659,9402.29%60Oct-25P&I

Nelson St1,170,000Floating36Oct-23Interest only

12,159,940

Total Existing Loan Facilities17,159,940

Proposed New Lending

Vendor Finance4,000,0006%60Mar-27Interest only (2 years) then also $20k principal per month

BNZ Finance7,500,0005.22%36Mar-25Three year interest only

Senior Trust Finance1,500,00010.75%30Sep-24Extension to existing facility

13,000,000

New Total Debt Facilities30,159,940


14521281_1 12

Facility on an ‘as is, where is’ basis. All fixtures and fittings at the Aldwins Facility are included in the

Acquisition.


EFFECTS OF RESOLUTION


Effect of Resolution passing


If the Resolution is passed and Completion occurs:


• AHL will own Aldwins Facility, adding to its portfolio of owned aged care facilities in New Zealand.

The Aldwins Facility will be the first aged care facility that PHL has acquired in a main city of New

Zealand and its first in the South Island;


• AHL’s operating expenses will immediately reduce by paying interest costs rather than rent costs;

and


• AHL will place an increased sales and marketing focus on building occupancy at the Aldwins

Facility with a goal of reaching profitability as quickly as possible.


The key risks associated with the Acquisition are:


• failing to increase occupancy levels to reach profitability at the Aldwins Facility and operating

profits at PHL’s other three other aged care facilities being insufficient to fund continued losses

at the Aldwins Facility.


• As occupancy grows at the Aldwins Facility, securing the necessary staffing (particularly

nurses). As reported widely in the media there is a national shortage of nurses at the present

time. The COVID-19 pandemic has exacerbated this issue for the aged care sector due to

border closures and vaccine mandates reducing the availability of labour. As pandemic

restrictions are lifted it is expected that this risk will reduce.


• The increase in group debt associated with funding the acquisition of the Aldwins Facility. The

BNZ Finance is on a variable interest rate and interest costs associated with that lending may

increase. In addition, when Group debt facilities mature, the Group must either refinance those

facilities or repay them from the proceeds of a capital raising or asset sales. There is no

assurance that they will be able to be refinanced.


Effect of Resolution not passing


The effect of the Resolution not passing is as follows:


• AHL will not complete the Acquisition. AHL will continue to lease the Aldwins Facility from the

Vendor at a cost that is higher than the cost of servicing the Debt Facilities meaning AHL will

require greater financial support for longer from the Group before reaching profitability;


• PHL will consider the ongoing viability of the Aldwins Facility against other uses of capital for

growing shareholder value. Alternatives would include looking to sell the business and Lease of

the Aldwins Facility or otherwise winding up AHL; and


• The Group will incur sunk costs of approximately $120,000 in having pursued this acquisition

through legal fees, registry fees, regulatory fees and finance establishment charges.


REQUIREMENTS FOR RESOLUTION


Shareholder approval is required under Listing Rule 5.1.1(b) by way of ordinary resolution.


Listing Rule 5.1.1(b) provides that, except with the prior approval by an ordinary resolution, PHL may

not enter into any transaction or series of transactions to acquire, sell, exchange, or otherwise dispose

of assets of PHL in respect of which the gross value is in excess of 50% of the average market

capitalisation of PHL.


14521281_1 13


The Acquisition constitutes a ‘transaction’ under Listing Rule 5.1.1(b). In particular, the Acquisition

involves PHL acquiring assets having a gross value that exceeds 50% of the average market

capitalisation of PHL in that PHL’s average market capitalisation at 23 December 2021 (being the date

that shareholders were publicly notified of the Acquisition through the NZX market) was approximately

$21,285,000 and PHL will acquire the Aldwins Facility for a market value of $13,000,000.


The Acquisition does not constitute a major transaction for the purposes of section 129 of the Companies

Act 1993.



14521281_1 14

GLOSSARY


The following terms have the following meanings where used in this Notice of Meeting unless the context

otherwise requires:


Acquisition means the acquisition by AHL from the Vendor of the Aldwins Facility, further described in

this Notice of Meeting;


AHL means Aldwins House Limited (company number 7832936), a wholly owned subsidiary of PHL.


Aldwins Facility means the land and buildings at 62 Aldwins Road, Phillipstown, Christchurch operating

as an aged care facility;


BNZ Finance means the $7.5 million facility to be provided to AHL at Completion by Bank of New

Zealand and described in this Notice of Meeting;


Board means the board of directors of PHL;


Completion means completion of the Acquisition under the Purchase Agreement;


Debt Facilities means the Vendor Finance, the BNZ Finance and the Senior Trust Finance;


EBITDA means earnings before interest, tax expense, depreciation and amortisation of intangibles;


Explanatory Notes means the explanatory notes that form part of this Notice of Meeting;


Group means PHL and subsidiaries;


IFRS means New Zealand equivalents to international financial reporting standards;


Lease means the lease of the Aldwins Facility between AHL (as tenant) with the Vendor;


Listing Rules means the NZX Listing Rules dated 10 December 2020 and Listing Rule means a rule

contained in the NZX Listing Rules;


Meeting means the special meeting of shareholders of PHL to be held on 30 March 2022, starting at

11am;


Notice of Meeting or Notice means this notice of special meeting, including the Explanatory Notes;


NZ RegCo means NZX Regulation Limited;


PHL means Promisia Healthcare Limited;


Proxy Form means a proxy form in relation to this Notice of Meeting, a personalised copy of which

accompanies this Notice of Meeting;


Purchase Agreement means the Agreement for Sale and Purchase of Real Estate between AHL and

the Vendor dated 23 December 2021;


Purchase Price means $13,000,000 (plus GST, if any);


Ranfurly Manor means Ranfurly Manor No:1 Limited, a wholly owned subsidiary of PHL;


Resolution means the resolution set out in this Notice of Meeting;


Senior Trust Finance means the $1.5 million facility extension to be provided to Ranfurly Manor at

Completion by Senior Trust Retirement Village Income Generator Limited and described in this Notice

of Meeting;


14521281_1 15

Vendor means Teltower Limited (company number 1337170); and


Vendor Finance means the loan of $4 million to be provided by the Vendor to AHL at Completion as

described in this Notice of Meeting.

---

14481403_1














LODGE YOUR PROXY

Online:

https://investorcentre.linkmarketservices.co.nz/voting/PHL


Scan & email:

meetings@linkmarketservices.com Mail:

Use the enclosed reply paid

Deliver: envelope or address to :

Link Market Services Link Market Services

Level 30, PwC Tower PO Box 91976

15 Customs Street West, Auckland 1010 Auckland 1142

Scan this QR code with your smartphone and vote online


General Enquiries


+64 9 375 5998 | enquiries@linkmarketservices.com


PROXY FORM/ADMISSION CARD PROMISIA HEALTHCARE LIMITED SPECIAL MEETING OF SHAREHOLDERS


The Special Meeting of Shareholders of Promisia Healthcare Limited (the Company) will be held online via the Link Market Services Virtual

meeting platform at www.virtualmeeting.co.nz/phlsm22, on Wednesday, 30 March 2022, commencing at 11am.


Appointment of proxy

If you DO NOT propose to ATTEND the Special Meeting online, please complete and return this form (in accordance with the lodgement instructions

above) to be received by Link Market Services (the share registry), no later than 11am on Monday, 28 March 2022. You can also appoint your

proxy and vote on the resolutions on the reverse of this form online by going to https://investorcentre.linkmarketservices.co.nz/voting/PHL or by

scanning the QR code above with your smartphone. Your proxy need not be a Shareholder of the Company. You may appoint any of the Directors

as your proxy by entering “Director” in the relevant space on the reverse of this form followed by their name. Any Director who is appointed as a

discretionary proxy intends to vote in favour of the Resolution.


Voting of your holding

Direct your proxy how to vote by making the appropriate election, either online or on this Proxy Form, in respect of the item of business. If you

return this form without directing the proxy how to vote on any particular matter the proxy may vote as he/she thinks fit or abstain from voting If

this Proxy Form is returned duly signed by a Shareholder with voting instructions included, but without specifying a person that is appointed as

proxy, the Chair is deemed to be the proxy for the purpose of that form, but only to vote to the extent of the voting instructions provided.


Attending the Meeting

The Special meeting will be an online Meeting only. Shareholders may attend and vote at www.virtualmeeting.co.nz/phlsm22. If you will be

attending online, you will require your Holder Number for verification purposes. A corporation may appoint a person to attend and vote online as

its representative in the same manner as that in which it could appoint a proxy. That person need not also be a shareholder.


Signing instructions for proxy forms


Individual

Where the holding is in one name, the shareholder must sign the Proxy Form.


Joint Holding

If you are joint holders of shares, either of you may sign this Proxy Form. If the shareholder is a company, this Proxy Form must be signed on

behalf of the company by a person acting under the company’s express or implied authority.


Power of Attorney

If this Proxy Form has been signed under a power of attorney, a copy of the power of attorney under which it was signed (if not previously provided

to the Registrar), and a signed certificate of non-revocation of the power of attorney must accompany this Proxy Form.


Corporate Shareholder

In the case of a corporate shareholder, a duly authorised officer or director must sign this Proxy Form. Persons who sign on behalf of a corporate

shareholder must be acting with that corporate shareholder’s express or implied authority, or execute under the common seal of the corporate

shareholder (if it has one).





Go online to https://investorcentre.linkmarketservices.co.nz/voting/PHL to vote or turn over to complete the Proxy Form



14481403_1




PROXY/CORPORATE REPRESENTATIVE FORM


STEP 1: APPOINT A PROXY TO VOTE ON YOUR BEHALF

I/We being a shareholder/s of Promisia Healthcare Limited:


hereby appoint _____________________________________________at________________________________________________

(Full Name) (E-mail Address)


Or failing him/her_________________________________________at________________________________________________

(Full Name) (E-mail Address)

as my/our proxy to vote for me/us on my/our behalf at the Special Meeting of the Company to be held at 11am on Wednesday, 30 March 2022

and at any adjournment of that meeting.


STEP 2: ITEMS OF BUSINESS – PROXY VOTING INSTRUCTIONS

Complete this part if you have appointed a proxy above and you want to direct the proxy as to how the proxy should vote.

Please note: For each resolution you must tick one box. If you mark the abstain box for an item, you are directing your proxy not to vote on

your behalf when polling and your votes will not be counted computing the required majority, for that item.


To consider and, if thought fit, pass the following ordinary resolution:


Tick (✓) in box to vote

For Against Abstain Discretion

RESOLUTION


1.

Approval of Acquisition: That, under Listing Rule 5.1.1(b), PHL undertaking the

Acquisition and entering all associated financing for the Acquisition on the basis

described in this Notice of Meeting is approved.


   


and to vote on any resolutions to amend any of the resolutions, on any resolution so amended, and on any other resolution proposed at the meeting (or

any adjournment thereof). Unless otherwise instructed as above, the proxy will vote on each resolution as he/she sees fit, or may abstain from voting.

The proxy is appointed only in respect of the above meeting or any adjournment thereof.


STEP 3: SHAREHOLDER QUESTIONS

Shareholders attending the Meeting will have the opportunity to ask questions during the Meeting via the virtual meeting platform at

www.virtualmeeting.co.nz/phlsm22. If you cannot attend the Meeting but would like to ask a question, you can submit a question online by going to

investorcentre.linkmarketservices.co.nz/voting/PHL and completing the online validation process or complete the question section below and return

it to Link Market Services. Questions will need to be submitted by 11am. (New Zealand time) on Monday, 28 March 2022. The Board will address and

answer questions at the Meeting.








STEP 4: SIGN: SIGNATURE OF SHAREHOLDER(S) This section must be completed

Shareholder 1 Shareholder 2 Shareholder 3




or duly authorised officer or attorney or duly authorised officer or attorney or duly authorised officer or attorney


Contact Name __________________________________ Contact Daytime Telephone _______________________ Date ____________

Electronic Investor Communications: If you received the Notice of Meeting and Proxy Form by mail and wish to receive your future investor

communications by e-mail please provide your email address below.

Question:

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.